Literature DB >> 27167903

The double-edged sword of IFN-γ-dependent immune-based therapies.

Liza B John1,2, Phillip K Darcy1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27167903     DOI： 10.1038/icb.2016.37

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  9 in total

Review 1.  Immune checkpoint blockade in hematologic malignancies.

Authors:  Philippe Armand
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

2.  Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.

Authors:  Rory Rearden; Amelia Sah; Brianna Doff; Takumi Kobayashi; Sara J McKee; Graham R Leggatt; Stephen R Mattarollo
Journal:  Immunol Cell Biol       Date:  2016-01-20       Impact factor: 5.126

3.  NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.

Authors:  Stephen R Mattarollo; Alison C West; Kim Steegh; Helene Duret; Christophe Paget; Ben Martin; Geoffrey M Matthews; Jake Shortt; Marta Chesi; P Leif Bergsagel; Michael Bots; Johannes Zuber; Scott W Lowe; Ricky W Johnstone; Mark J Smyth
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

4.  An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.

Authors:  Alison C West; Stephen R Mattarollo; Jake Shortt; Leonie A Cluse; Ailsa J Christiansen; Mark J Smyth; Ricky W Johnstone
Journal:  Cancer Res       Date:  2013-10-24       Impact factor: 12.701

5.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

Review 6.  Acquired and intrinsic resistance in cancer immunotherapy.

Authors:  Sander Kelderman; Ton N M Schumacher; John B A G Haanen
Journal:  Mol Oncol       Date:  2014-07-24       Impact factor: 6.603

Review 7.  Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

Authors:  Stefan Löb; Alfred Königsrainer; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 8.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

9.  TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.

Authors:  Valentina Folgiero; Loredana Cifaldi; Giuseppina Li Pira; Bianca Maria Goffredo; Luciana Vinti; Franco Locatelli
Journal:  J Hematol Oncol       Date:  2015-04-16       Impact factor: 17.388
  9 in total
  2 in total

1.  Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.

Authors:  Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie
Journal:  Front Microbiol       Date:  2021-12-22       Impact factor: 5.640

2.  In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production.

Authors:  Yixin Xie; Min Wang; Zhihui Dong; Huan Song; Lianping Li; Min Yang; Pengling Li; Jingjing Tian; Kan Zhang; Xiaomeng Xia; Tingting Zhang; Aiguo Tang
Journal:  Mol Med Rep       Date:  2017-08-09       Impact factor: 2.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.